Sites smothered by technology solutions
Technology solutions help sponsors and CROs make better drug development decisions, streamline processes and reduce clinical trial costs. But for a majority of investigative sites, these same technologies get in the way of efficient operations and add to their already heavy workload. CenterWatch analysis suggests that investigative sites are inundated with a growing number of technologies that rarely interact with each other. Only 9% of global investigative sites surveyed report that technology solutions provided by sponsors and CROs to conduct clinical studies meet their operating needs “very well.”
Welcoming procurement onto the team
For decades, procurement professionals have been the Rodney Dangerfields of the pharmaceutical industry: they got no respect. Procurement held up projects, got bogged down in protracted budget and contract negotiations, and was a hassle. The function is now changing. Procurement is moving from the back room to front and center. Searching for new ways to improve the effectiveness of their collaborations with CROs and investigative sites, sponsor companies are looking at the procurement function as a more strategic relationship-driving asset. The role of procurement professionals is evolving from one focused almost exclusively on cost-savings and transactional activities to one focused more strategically on facilitating collaboration, innovation and efficiency.
To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.